📰 Abt News
Page 162 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
May 1, 2023
Arcblock (ABT) traded 2.9% lower against the US dollar during the twenty-four hour period ending at 23:00 PM Eastern on April 30th. One Arcblock token can currently be bought for $0.12 or 0.00000410 BTC on popular exchanges. Arcblock has a total market cap of $11.53 million and approximately $330,401.91 worth of Arcblock was traded on […]
May 1, 2023
Arcblock (ABT) traded 2.9% lower against the dollar during the 24-hour period ending at 23:00 PM E.T. on April 30th. One Arcblock token can now be bought for approximately $0.12 or 0.00000410 BTC on exchanges. In the last week, Arcblock has traded up 7.8% against the dollar. Arcblock has a market cap of $11.53 million […]
May 1, 2023
Arcblock (ABT) traded down 19.8% against the US dollar during the 24-hour period ending at 9:00 AM Eastern on May 1st. In the last seven days, Arcblock has traded down 10.2% against the US dollar. One Arcblock token can currently be purchased for about $0.0968 or 0.00000339 BTC on major exchanges. Arcblock has a market […]
May 1, 2023
Arcblock (ABT) traded down 19.8% against the US dollar during the 24-hour period ending at 9:00 AM Eastern on May 1st. In the last seven days, Arcblock has traded down 10.2% against the US dollar. One Arcblock token can currently be purchased for about $0.0968 or 0.00000339 BTC on major exchanges. Arcblock has a market […]
May 1, 2023
Vaughan David Investments LLC IL lessened its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 412,039 shares of the healthcare product maker’s stock after selling 9,720 shares during the quarter. […]
May 1, 2023
Israel Discount Bank of New York trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 6.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,853 shares of the healthcare product maker’s stock after selling 735 […]
May 1, 2023
Keystone Financial Group lessened its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 10.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 19,209 shares of the healthcare product maker’s stock after selling 2,246 shares during the period. Keystone Financial Group’s holdings […]
May 1, 2023
Vaughan David Investments LLC IL decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 412,039 shares of the healthcare product maker’s stock after selling 9,720 shares during the period. Abbott Laboratories comprises […]
May 1, 2023
Benjamin Edwards Inc. increased its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 5.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 35,423 shares of the healthcare product maker’s stock after acquiring an additional 1,798 shares during the period. Abbott Laboratories accounts for 1.0% of Benjamin Edwards Inc.’s holdings, […]
May 1, 2023
Northcape Wealth Management LLC trimmed its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 45.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,222 shares of the healthcare product maker’s stock after selling 21,494 shares during the quarter. Abbott Laboratories comprises 1.6% of […]